Delivery Order SPE2DB22D2206-SPE2DB25FHE99
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $55K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,624.36 for TREMFYA 100 mg/mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a monoclonal antibody used to treat moderate to severe plaque psoriasis and other...
- The Defense Logistics Agency awarded a $60,405.91 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 7, 2025, with completion scheduled for August 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a biologic immunosuppressant used to treat plaque psoriasis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $9,132.68 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and...
- The Defense Logistics Agency awarded a delivery order valued at $69,595.64 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML syringes on October 20, 2025, with completion expected by October 21, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a biologic immunosuppressant medication used primarily to treat moderate-to-severe plaque...
- The Defense Logistics Agency awarded a $19,499.34 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a $59,710.11 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes, with performance to be completed by July 31, 2025. This is a firm fixed price, non-competitive delivery order executed on July 30, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $7,269.70 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TREMFYA 200 mg/2 ml syringes. This competitive, non-set-aside contract has a firm fixed price structure with an ultimate completion date of September 4, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used in the treatment of plaque psoriasis and psoriatic arthritis, and...
- The Defense Logistics Agency awarded a delivery order valued at $13,888.78 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML syringes on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is an injectable immunosuppressant medication used to treat psoriasis and psoriatic...
- The Defense Logistics Agency awarded a $29,944.86 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania facility. TREMFYA is a biologic medication used primarily for treating moderate-to-severe plaque psoriasis and is being procured to...
- The Defense Logistics Agency awarded a delivery order valued at $38,843.14 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of TREMFYA 100 mg/ml in pen format. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025. TREMFYA is a branded pharmaceutical used...